CELLULAR & BIOCHEMICAL BASIS OF DIABETIC MICROANGIOPATHY
CELLULAR & BIOCHEMICAL BASIS OF DIABETIC MICROANGIOPATHY
批准号:
6486781
负责人:
JOSEPH R WILLIAMSON
金额:
$15.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2002-07-31
中文摘要
几种不同动物的体内和体外观察结果
糖尿病模型和人红细胞中的结果表明,
葡萄糖水平本身,独立于糖尿病环境,诱导
代谢失衡导致缺氧样还原性应激。
糖尿病环境引起的几种代谢失衡可能
有助于还原压力,然而最好的特点是
不平衡是山梨糖醇氧化为果糖的增加,
山梨醇脱氢酶将NAD+还原为NADH。 还原应力
通过多种机制促进氧化应激,
许多酶的活性和生物化学的不平衡
糖尿病并发症的发病机制。 代谢诱导
还原应激似乎是一个典型的特征,
控制糖尿病之前,并有助于,发展
一般糖尿病并发症,包括缺血性视网膜病变,
神经病变
英文摘要
In vivo and in vitro observations in several different animal
models of diabetes and in human erythrocytes indicate that elevated
glucose levels per se, independent of the diabetic milieu, induce
metabolic imbalances that cause hypoxia-like reductive stress.
Several metabolic imbalances induced by the diabetic milieu may
contribute to reductive stress, however the best characterized
imbalance is increased oxidation of sorbitol to fructose couples to
reduction of NAD+ to NADH by sorbitol dehydrogenase. Reductive stress
contributes to oxidative stress via several mechanisms and impacts on
the activity of numerous enzymes and biochemical imbalances implicated
in the pathogenesis of diabetic complications. Metabolically-induced
reductive stress appears to be a characteristic feature of poorly
controlled diabetes which precedes, and contributes to, development of
diabetic complications in general including ischemic retinopathy and
neuropathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CELLULAR & BIOCHEMICAL BASIS OF DIABETIC MICROANGIOPATHY
-
批准号:6665901
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CORE--MORPHOLOGY FACILITY
-
批准号:6414866
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2000
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CELLULAR & BIOCHEMICAL BASIS OF DIABETIC MICROANGIOPATHY
-
批准号:6336851
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2000
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CORE--MORPHOLOGY FACILITY
-
批准号:6217556
-
项目类别:
-
资助金额:$24.38万
-
财政年份:1999
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CORE--MORPHOLOGY FACILITY
-
批准号:6301029
-
项目类别:
-
资助金额:$24.38万
-
财政年份:1999
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CORE--MORPHOLOGY FACILITY
-
批准号:6105097
-
项目类别:
-
资助金额:$24.38万
-
财政年份:1999
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
BLOOD FLOW IN MURINE SKELETAL MUSCLE: GLUCOSE METAB VIA SORBITOL PATHWAY
-
批准号:6118639
-
项目类别:
-
资助金额:$0.08万
-
财政年份:1998
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CORE--MORPHOLOGY FACILITY
-
批准号:6270491
-
项目类别:
-
资助金额:$24.38万
-
财政年份:1998
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
INCREASED BLOOD FLOW IN MURINE SKELETAL MUSCLE OVEREXPRESSING GLUT 1: SORBITAL
-
批准号:6249791
-
项目类别:
-
资助金额:$0.42万
-
财政年份:1997
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CELLULAR & BIOCHEMICAL BASIS OF DIABETIC MICROANGIOPATHY
-
批准号:6249777
-
项目类别:
-
资助金额:$0.42万
-
财政年份:1997
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
CORE--MORPHOLOGY FACILITY
-
批准号:6238746
-
项目类别:
-
资助金额:$21.31万
-
财政年份:1996
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:3356933
-
项目类别:
-
资助金额:$21.14万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:3356931
-
项目类别:
-
资助金额:$21.14万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:3356936
-
项目类别:
-
资助金额:$22.6万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:3356932
-
项目类别:
-
资助金额:$23.83万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:2219458
-
项目类别:
-
资助金额:$28.5万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:2219456
-
项目类别:
-
资助金额:$26.58万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:3356935
-
项目类别:
-
资助金额:$21.73万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:3356934
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
PATHOGENETIC MECHANISMS IN DIABETIC VASCULAR DISEASE
-
批准号:2219457
-
项目类别:
-
资助金额:$27.17万
-
财政年份:1988
-
负责人:JOSEPH R WILLIAMSON
-
依托单位:
海外基金